Cacna1etm1.1Tsch
Targeted Allele Detail
|
Symbol: |
Cacna1etm1.1Tsch |
Name: |
calcium channel, voltage-dependent, R type, alpha 1E subunit; targeted mutation 1.1, Toni Schneider |
MGI ID: |
MGI:3526823 |
Synonyms: |
Cav2.3- |
Gene: |
Cacna1e Location: Chr1:154266477-154760247 bp, - strand Genetic Position: Chr1, 66.14 cM
|
Alliance: |
Cacna1etm1.1Tsch page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:95636
|
Parent Cell Line: |
E14.1 (ES Cell)
|
Strain of Origin: |
129P2/OlaHsd
|
|
Allele Type: |
|
Targeted (Null/knockout) |
Mutation: |
|
Intragenic deletion
|
|
|
Mutation details: Crossing Cacna1etm1Tsch mice with a strain expressing Cre ubiquitously resulted in the excision of exon 2, which encodes the first transmembrane segment of domain 1 and the adjacent loop to IS2. RT-PCR analysis revealed a different splice pattern for exon 1 than expected, producing a novel second exon of 204 bp that contained an in-frame stop codon. Western blot analysis of mutant brain microsomal membranes detected no protein expression from any Cacna1e subunit.
(J:95636)
|
|
|
Key: |
hm |
homozygous |
ht |
heterozygous |
tg |
involves transgenes |
√ |
phenotype observed |
cn |
conditional genotype |
cx |
complex: > 1 genome feature |
ot |
other: hemizygous, indeterminate,... |
N |
normal phenotype |
|
Genotype/ Background: |
| Allelic Composition | Genetic Background | Cell Line(s) |
---|
Loading... | | | involves: BALB/cJ * C57BL/6 | | | | involves: C57BL/6 | |
|
Phenotypes: |
Affected Systems |
|
|
|
endocrine/exocrine glands
|
√
|
√
|
decreased pancreatic alpha cell number
|
|
√
|
abnormal glucagon secretion
|
|
√
|
decreased glucagon secretion
|
√
|
|
abnormal pancreatic beta cell physiology
|
|
√
|
decreased insulin secretion
|
√
|
√
|
growth/size/body
|
√
|
|
increased body weight
|
√
|
|
homeostasis/metabolism
|
√
|
√
|
abnormal glucagon secretion
|
|
√
|
decreased glucagon secretion
|
√
|
|
decreased insulin secretion
|
√
|
√
|
increased circulating glucose level
|
√
|
√
|
hyperglycemia
|
√
|
|
decreased circulating glucagon level
|
|
√
|
impaired glucose tolerance
|
√
|
√
|
decreased physiological sensitivity to xenobiotic
|
√
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Original: |
J:95636 Pereverzev A, et al., Disturbances in glucose-tolerance, insulin-release, and stress-induced hyperglycemia upon disruption of the Ca(v)2.3 (alpha 1E) subunit of voltage-gated Ca(2+) channels. Mol Endocrinol. 2002 Apr;16(4):884-95 |
All: |
20 reference(s) |
|